(tradenames include Ferriprox
) is an oral drug
that chelates iron
and is used to treat thalassaemia major
It is currently licenced for use in the Europe and Asia, but not in Canada and the United States.
Deferiprone was at the centre of a protracted struggle between Nancy Olivieri
, a Canadian haematologist
, and the Hospital for Sick Children
and pharmaceutical giant Apotex
, that started in 1996
Dr. Olivieri's data suggested that deferiprone leads to progressive hepatic fibrosis
, a finding which is in dispute.